Posters/Exhibits/Break > Session
Posters/Exhibits/Break
Presentations
A1. ANTICOAGULATION CLINICS | |||||
|
(701) NECESSITY OF ANTI-XA LEVEL MONITORING FOR PROPHYLACTIC ENOXAPARIN IN CHILDREN AND ADOLESCENTS: A SINGLE INSTITUTION EXPERIENCE Rene Gonzalez1, Abigail Davison1,2, Sarah E. Sartain1,2, Clay T. Cohen1,2. 1Texas Children's Hospital, Houston, TX, USA 2Baylor College of Medicine, Houston, TX, USA |
||||
A5. BLOOD COAGULATION AND FIBRINOLYTIC FACTORS | |||||
|
(703) INSIGHT INTO ATHN 16: TREATMENT OF BLEEDING EVENTS IN PATIENTS WITH CONGENITAL HEMOPHILIA A OR B WITH INHIBITORS TO EVALUATE THE SAFETY OF COAGULATION FACTOR VIIA (RECOMBINANT)-JNCW Tammuella Chrisentery-Singleton1, SUCHITRA ACHARYA2, SANJAY AHUJA3, LAUREN AMOS4, MEERA CHITLUR5, MIGUEL ESCOBAR6, ASHLEY EASON7, SHVETA GUPTA8, PHILLIP KURIAKOSE9, SHARON PENNINGTON10, RAJIV PRUTHI11, MICHAEL RECHT12, SPENCER SULLIVAN13, DORIS QUON14, ALLISON WHEELER15, MARK REDING16. 1American Thrombosis and Hemostasis Network, Rochester, NY, USA 2Northwell Health Hemostasis and Thrombosis Center, New Hyde Park, NY, USA 3University Hospitals Health System Cleveland, Cleveland, OH, USA 4Children’s Mercy Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA 5Central Michigan University/Children’s Hospital of Michigan, Detroit, MI, USA 6University of Texas Health Science Center, Houston, TX, USA 7Willett Children's Hemophilia Treatment Center at Memorial Health, Savannah, GA, USA 8Arnold Palmer Hospital for Children, Orlando, FL, USA 9Henry Ford Health System, Detroit, MI, USA 10Louisiana Center for Advanced Medicine, Slidell, LA, USA 11Mayo Clinic, Rochester, MN, USA 12National Blood Disorders Foundation, New York, NY, USA 13Mississippi Center for Advanced Medicine, Madison, MS, USA 14Orthopaedic Hemophilia Treatment Center, Los Angeles, CA, USA 15Vanderbilt University Medical Center, Nashville, TN, USA 16University of Minnesota Medical Center, Minneapolis, MN, USA |
||||
|
(704) IMPACT OF MRNA COVID-19 VACCINATION ON D-DIMER LEVELS AND ANTI-PF4 SEROCONVERSION IN HEALTHY ADULTS: A SYSTEMATIC REVIEW Evan Y Maroun M.S., Megan Centrella, Grace Hansen, Trevor Forsberg, Tariq Rahaman M.L.I.S., Hoang Nguyen M.D. Ph.D.. Nova Southeastern University College of Osteopathic Medicine, Fort Lauderdale, FL, USA |
||||
|
(705) UTILITY OF THROMBOELASTOGRAPHY VERSUS ROUTINE COAGULATION TESTS: CARDIAC BYPASS SURGERY. ISABEL RODRIGUEZ MARTIN. Hospital Universitario Virgen del Rocio, SEVILLA, Spain |
|||||
A6. DISORDERS OF COAGULATION OR FIBRINOLYSIS | |||||
|
(706) CLINICAL OUTCOMES OF CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA WITH AND WITHOUT PROPHYLAXIS THERAPY: A MULTINATIONAL CHART REVIEW STUDY Paul Coppo1, Marie Scully2, Johanna A Kremer Hovinga3, Maria Jose Aragon4, Parth Patwari5, Linda T Wang5, Björn Mellgård5, Ragy Saad5. 1APHP.6–Reference Center for Thrombotic Microangiopathies (CNR-MAT), Hôpital St Antoine, Paris, France 2University College London Hospitals NHS Foundation Trust, London, United Kingdom 3Department of Hematology and Central Hematology Laboratory, Bern University Hospital, Bern, Switzerland 4HCD Economics, Knutsford, United Kingdom 5Takeda Development Center Americas, Inc., Cambridge, MA, USA |
||||
|
(707) THE IMPACT OF MULTIDISCIPLINARY PERINATAL CARE FOR WOMEN WITH BLEEDING DISORDERS Vanessa Giuliano1, Natalya E. O’Neill1, Shamshah Aratia7, Shalene Wong7, Allison Rupnaraine,7, Rebecca Sampat7, Filomena Meffe2,3, Jeffrey Wassermann8, Jillian M. Baker4-6, Grace Tang7, Michelle Sholzberg1,7,9,10. 1Department of Medicine, University of Toronto, Toronto, ON, Canada 2Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada 3Department of Obstetrics and Gynecology, St. Michael’s Hospital, Toronto, ON, Canada 4Department of Pediatrics, St. Michael’s Hospital, Toronto, ON, Canada 5Department of Paediatrics, Division of Haematology-Oncology, The Hospital for Sick Children, Toronto, ON, Canada 6Department of Paediatrics, University of Toronto, Toronto, ON, Canada 7St. Michael's Hospital, University of Toronto, Toronto, ON, Canada 8Department Of Anaesthesia, University of Toronto, Toronto, ON, Canada 9Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada 10Li Ka Shing Knowledge Institute, Toronto, ON, Canada |
||||
|
(708) TEMPORAL TRENDS AND PREDICTORS OF VENOUS THROMBOEMBOLISM IN HOSPITALIZED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS Michael Imeh1, Ani Gvajaia1, Chukwunonye Amaeshi2, Fidelis Uwumiro3. 1Lincoln Medical and Mental Health Centre, Bronx, NY, USA 2Montefiore Medical Centre, Bronx, NY, USA 3University of Benin Teaching Hospital, Benin, Nigeria |
||||
|
(709) DEEP PHENOTYPING REVEALS A HIGH PREVALENCE OF DISTRESSING BLEEDING SYMPTOMS IN PATIENTS WITH HYPERMOBILE EHLERS DANLOS SYNDROME (HEDS) SPECTRUM DISEASE . Rohith Jesudas1, Sarah Mathena 2, Kenneth L. Zhang3, Christina Laukaitis3,4, Jennifer Andrews2. 1St. Jude Children’s Research Hospital, Memphis, TN, USA 2University of Arizona, Tucson, AZ, USA 3Carle Illinois College of Medicine, Urbana, IL, USA 4Carle Foundation Hospital, Urbana, IL, USA |
||||
|
(710) INDIRECT COMPARISON OF PROPHYLAXIS EFFICACY BETWEEN SIMOCTOCOG ALFA AND EFANESOCTOCOG ALFA IN SEVERE HEMOPHILIA A AND THEIR COST IN THE UNITED STATES Craig M. Kessler1, Fernando F. Corrales-Medina2. 1Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, DC, USA 2University of Miami-Miller School of Medicine, and University of Miami-Hemophilia Treatment Center, Miami, FL, USA |
||||
|
(711) RISK OF THROMBOSIS IN SGLT2 INHIBITOR-ASSOCIATED ERYTHROCYTOSIS: A MULTI-CENTER PROPENSITY-MATCHED ANALYSIS Meric Mericliler1,2. 1Division of Hematology and Medical Oncology, Virginia Commonwealth University Health, Richmond, VA, USA 2Massey Cancer Center, Richmond, VA, USA |
||||
|
(712) HOSPITALIZATION OUTCOMES FROM VENOUS THROMBOEMBOLISM IN CANCER PATIENTS: AN ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATA FROM 2016 TO 2019 Youjin oh, Alejandro Vallejo, Alexandra Sueldo, Lina james, Angelo Caputi Zuniga, Ayobami Olafimihan, Ekrem Turk. John H. Stroger Jr Hospital, Chicago, IL, USA |
||||
|
(713) ACCURATE MEASUREMENT OF FACTOR VIII ACTIVITY AND INHIBITORS IN THE PRESENCE OF MIM8 William Pickering1, Karin Nana Weldingh2, Mary Robinson1, Caroline Cogswell1, Wan Hui Ong Clausen2, Mirella Ezban2, Vlady Ostrow3. 1Labcorp Colorado Coagulation, Englewood, CO, USA 2Novo Nordisk A/S, Søborg, Denmark 3Novo Nordisk Inc., Plainsboro, NJ, USA |
||||
|
(714) FIRST REAL-WORLD EXPERIENCE ADMINISTERING ETRANACOGENE DEZAPARVOVEC GENE THERAPY FOR PEOPLE WITH HEMOPHILIA B Matthew Ryan1, Andrea B. Miller1, Patrick O'Hearn1, Vidhi Desai2, Nathan Visweshwar3. 1Hemophilia Outreach Center, Green Bay, WI, USA 2CSL Behring, King of Prussia, PA, USA 3University of South Florida, Tampa, FL, USA |
||||
A7. PATHOPHYSIOLOGY OF THROMBOSIS | |||||
|
(715) THROMBOSIS RATES AND USE OF THROMBOPROPHYLAXIS AFTER DISCHARGE FROM GYNECOLOGIC CANCER-RELATED SURGERY Leticia Campoverde, Alyssa Mercadel, Dan Morgenster, Asaad Trabolsi, Thomas Plate IV, Rachel Kronenfeld, Wei Zhao, Matthew Schlumbrecht , Gerald Soff. University of Miami, Miami, FL, USA |
||||
A8. ANTITHROMBOTIC THERAPY | |||||
|
(716) INCIDENCE OF GASTROINTESTINAL BLEEDING IN HIGH-RISK CARDIOVASCULAR PATIENTS TAKING ANTITHROMBOTIC MEDICATIONS WITH PROTON PUMP INHIBITORS Mark Edwards1, Xiaowen Kong1, Jacob Kurlander1, Scott Kaatz2, James B Froehlich1, Twylla Tassava3, Christopher Giuliano4, Geoffrey D Barnes1. 1University of Michigan-Michigan Medicine, Ann Arbor, MI, USA 2Henry Ford Health- Division of Hospital Medicine, Detroit, MI, USA 3Trinity Health-Ann Arbor, Ann Arbor, MI, USA 4Ascension- St. John Hospital, Detroit, MI, USA |
||||
|
(717) ACCURACY OF A WARFARIN CLINICAL DOSING ALGORITHM ENRICHED WITH GENETIC INFORMATION COMPARED TO THE USE OF CLINICAL ALGORITHM Amr Fahmi1, Ahmed El Bardissy1, Mohamed Saad1, Mohamed Nabil1, Loulia Bader2, Mohamed Kassem1, Ahmed Mahfouz1, Hazem Elewa2. 1Hamad Medical Corporation, Doha, Qatar 2College of Pharmacy, QU Health, Qatar University, Doha, Qatar |
||||
A9. INFORMATIONAL ABSTRACT (POSTER ONLY) | |||||
|
(718) SAFETY AND COST-EFFECTIVENESS ANALYSIS OF ANTICOAGULATION THERAPY IN ADULT PATIENTS UNDERGOING EXTRACORPOREAL MEMBRANE OXYGENATION Amanda Arenella1, Michael Calloway1, Joshua Oh2. 1Department of Health Economics and Outcomes Research, Grifols SSNA, Research Triangle Park, NC, USA 2University of North Carolina at Charlotte, College of Health and Human Services, Department of Public Health Sciences, Charlotte, NC, USA |
||||
|
(719) WHAT IS THE ROLE OF FAMILY HISTORY IN THE MANAGEMENT OF VTE? Ayan Ramanathan1, Ishan Dhaneshwar1, Joseph Caprini3, Fakiha Siddiqui2, Atul Laddu1, Jawed Fareed2, Krish Punyarthi1, Richa Mahajan1. 1Global Thrombosis Forum, Suwanee, GA, USA 2Loyola University, Chicago, IL, USA 3Northshore University Health System, Evanston, IL, USA |
||||